Michele Lee is a nationally recognized leader in vascular access, infusion therapy, and clinical education, with more than three decades of experience advancing evidence-based practices across acute care, oncology, and outpatient settings. As Chief Clinical Officer of ONNIX she provides clinical and operational leadership as the company brings its EDTA-based catheter lock/flush solution toward clinical use. Michele has long championed the clinical promise of ONNIX’s lock technology—recognizing its potential to improve patient safety, reduce infections, and modernize central line care well before broader adoption. 

​

Michele led vascular access organizations that introduced PICC technologies, and best practices throughout Tennessee and the nation. For over 30 years, she has trained nurses, built vascular access programs across the U.S., and served as a trusted clinical partner to hospitals, health systems, and regulatory bodies. Since 2007, she has been a consultant to the Tennessee Board of Nursing on vascular access and infusion therapy standards, and she is the developer of Tennessee’s widely adopted 40-Hour IV Therapy Certification Course for nurses. 

​

Earlier in her career, Michele served as a pediatric oncology and vascular access nurse at St. Jude Children’s Research Hospital and later as a national educator with Genentech, where she provided training on infusion safety, vascular access, and infection prevention to clinicians across the country. 

Michele brings deep expertise in patient safety, clinician education, and central line management. Her decades of frontline practice, program development, and early advocacy for EDTA-based lock solutions make her an essential clinical leader as Onnix advances a next-generation catheter lock/flush technology aimed at eliminating occlusions, reducing infections and improving patient outcomes.